Tivozanib: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Tivozanib. Educational only — not medical advice.

Labeled uses

FOTIVDA is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.

Source: FDA labeling via NIH DailyMed (set de77155c…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.